Status:
COMPLETED
High Velocity Nasal Insufflation Versus Continuous Positive Airway Pressure in COVID 19 Pneumonic Patients
Lead Sponsor:
Mansoura University
Conditions:
COVID-19 Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
compare the efficacy of High-Velocity Nasal Insufflation (HVNI) versus Continuous Positive Airway Pressure (CPAP) in managing COVID 19 pneumonic patients with acute type 1 respiratory failure
Detailed Description
A prospective randomized controlled trial was conducted on 108 patients with COVID 19 pneumonia with acute hypoxemic respiratory failure at Mansoura University Hospitals to compare the efficacy of Hig...
Eligibility Criteria
Inclusion
- Patients aged above 18 years with COVID 19 pneumonia with acute type 1 respiratory failure were included.
Exclusion
- patients with hypercapnic respiratory failure.
- patients with a disturbed level of consciousness and/or a high risk of aspiration
- individuals with hypotension
- patients requiring invasive mechanical ventilation.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT07213518
Start Date
January 1 2022
End Date
January 1 2023
Last Update
October 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohamed AbdElmoniem
Al Mansurah, Egypt, 35516